Quel est le prix pour Elbit Medical Technologies Ltd (EMTC-M)

Le prix pour Elbit Medical Technologies Ltd (EMTC-M) est $0.07188945

Quelle est la capitalisation boursière pour Elbit Medical Technologies Ltd (EMTC-M)

La capitalisation boursière pour Elbit Medical Technologies Ltd (EMTC-M) est $65.22K

Elbit Medical Technologies Ltd (EMTC-M) Ratio P/S

Elbit Medical Technologies Ltd functions as an investment holding company, with its core activities centered on the innovation, production, and global commercialization of therapeutic medical devices. The company maintains a presence across the United States, Europe, and other international territories. A key initiative involves the advancement of a magnetic resonance imaging (MRI) guided focused ultrasound treatment system, designed to tackle a range of medical challenges, including various cancers (oncology), gynecological conditions, neurological disorders, and tumors. Additionally, Elbit Medical Technologies is engaged in the extensive study and creation of medical products leveraging stem cells, predominantly sourced from umbilical cord blood. These stem cell applications are critical for bone marrow transplants in individuals affected by leukemia, lymphatic system cancers, non-malignant hematological diseases, and inherited metabolic genetic conditions. Headquartered in Petah Tikva, Israel, Elbit Medical Technologies Ltd is a wholly-owned subsidiary of Exigent Management Ltd.

Année	Ratio P/S	Changez
Pas assez de données pour les dates fournies.

Année

Ratio P/S

Changez

Pas assez de données pour les dates fournies.

Entreprise	Ratio P/S	Différence de Ratio P/S	Pays
Abbott Laboratories ABT.US	3.95	-	US
Stryker Corporation SYK.US	4.83	-	US
Medtronic plc MDT.US	2.78	-	IE
Boston Scientific Corporation BSX.US	3.31	-	US
Edwards Lifesciences Corporation EW.US	7.61	-	US

Entreprise

Ratio P/S

Différence de Ratio P/S

Pays